Helena Grinberg-Rashi, Ph.D., RN, CCPO Chief Clinical and Product Officer
Dr. Grinberg-Rashi has vast experience in clinical development and regulatory strategy in the medical devices, biotechnology and pharmaceutical industries.
Before joining Beta-O2, Dr. Grinberg-Rashi held leading clinical and regulatory positions in the fields of neurology, oncology and gastroenterology, among others, as VP Clinical and Regulatory Affairs at Exalenz Biosciences (TASE: EXEN) and Vecta Pharmaceuticals.
Dr. Grinberg-Rashi received her M.Sc. summa cum laude and PhD in genetics and molecular medicine both from Tel-Aviv University’s Sackler School of Medicine. She developed methods and diagnostic tools for predicting cancer metastasis and led clinical research in several areas including leukemia and lung cancer at the Sheba Cancer Research Center. Dr. Grinberg-Rashi holds a patent and her academic work has been published regularly.
Dr. Grinberg-Rashi is also a registered nurse, with clinical experience in psychiatry, oncology, community health and family medicine.